Literature DB >> 24394816

Point: should fibrinolytics be routinely administered intrapleurally for management of a complicated parapneumonic effusion? Yes.

John P Corcoran1, Najib M Rahman2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24394816     DOI： 10.1378/chest.13-2354

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  6 in total

1.  Rebuttal from Drs Colice and Idell.

Authors:  Gene L Colice; Steven Idell
Journal:  Chest       Date:  2014-01       Impact factor: 9.410

2.  Response.

Authors:  Gene L Colice; Steven Idell
Journal:  Chest       Date:  2014-09       Impact factor: 9.410

Review 3.  Infectious pleural effusion status and treatment progress.

Authors:  Wei Yang; Bo Zhang; Ze-Ming Zhang
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

4.  Modified single-port non-intubated video-assisted thoracoscopic decortication in high-risk parapneumonic empyema patients.

Authors:  Chen-Hao Hsiao; Ke-Cheng Chen; Jin-Shing Chen
Journal:  Surg Endosc       Date:  2016-08-12       Impact factor: 4.584

5.  Safety and Efficacy of Intrapleural Tissue Plasminogen Activator and DNase during Extended Use in Complicated Pleural Space Infections.

Authors:  Jason R McClune; Candice L Wilshire; Jed A Gorden; Brian E Louie; Alexander S Farviar; Michael J Stefanski; Eric Vallieres; Ralph W Aye; Christopher R Gilbert
Journal:  Can Respir J       Date:  2016-06-30       Impact factor: 2.409

6.  A case of Lemierre's syndrome with septic shock and complicated parapneumonic effusions requiring intrapleural fibrinolysis.

Authors:  Daniel P Croft; Sean M Philippo; Paritosh Prasad
Journal:  Respir Med Case Rep       Date:  2015-08-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.